Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics (LENZ) Accumulated Depreciation & Amortization: 2022-2023

Historic Accumulated Depreciation & Amortization for Therapeutics (LENZ) over the last 2 years, with Sep 2023 value amounting to $838,000.

  • Therapeutics' Accumulated Depreciation & Amortization fell 66.81% to $838,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $11.2 million, marking a year-over-year change of. This contributed to the annual value of $58,000 for FY2024, which is 286.67% up from last year.
  • Latest data reveals that Therapeutics reported Accumulated Depreciation & Amortization of $838,000 as of Q3 2023, which was down 74.41% from $3.3 million recorded in Q2 2023.
  • In the past 5 years, Therapeutics' Accumulated Depreciation & Amortization registered a high of $3.9 million during Q1 2023, and its lowest value of $838,000 during Q3 2023.
  • In the last 2 years, Therapeutics' Accumulated Depreciation & Amortization had a median value of $2.5 million in 2022 and averaged $2.4 million.
  • Examining YoY changes over the last 5 years, Therapeutics' Accumulated Depreciation & Amortization showed a top increase of 198.22% in 2023 and a maximum decrease of 66.81% in 2023.
  • Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $3.2 million in 2022, then tumbled by 66.81% to $838,000 in 2023.
  • Its last three reported values are $838,000 in Q3 2023, $3.3 million for Q2 2023, and $3.9 million during Q1 2023.